Geldanamycin has also been observed to downregulate the expression of the cell cycle genes CCNB1 and UBE2C in COVID-19 [31], which can potentially serve as effective antiviral and anti-inflammatory agents [38]. The gene discussed is CCNB1; the disease is COVID-19.